Table 5.
Susceptibilities of individual serotypes and grouped serotypes
|
|
|
All antibiotics* |
Without cotrimoxazole |
||
---|---|---|---|---|---|---|
Serotype | No. of strains | Missing | I/R | P-value | I/R | P-value |
1 |
34 |
8 |
25 (96.2%) |
ns |
2 (7.7%) |
ns |
5 |
22 |
6 |
16 (100%) |
ns |
1 (6.2%) |
ns |
19 F |
18 |
6 |
12 (100%) |
ns |
6 (50%) |
0.011 |
6B |
18 |
5 |
13 (100%) |
ns |
5 (38.5%) |
ns (0.069) |
14 |
17 |
10 |
7 (100%) |
ns |
3 (42.9%) |
ns |
3 |
12 |
3 |
3 (33.3%) |
<0.001 |
1 (11.1%) |
ns |
19A |
10 |
2 |
8 (100%) |
ns |
3 (37.5%) |
ns |
6A |
7 |
4 |
3 (100%) |
ns |
2 (66.7%) |
ns (0.089) |
8 |
7 |
0 |
1 (14.3%) |
<0.001 |
0 (0%) |
ns |
PCV10 types |
128 |
41 |
85 (97.7%) |
<0.001 |
19 (21.8%) |
ns |
PCV13 types |
157 |
50 |
99 (92.5%) |
0.021 |
25 (23.4%) |
0.033 |
Total | 244 | 83 | 142 (88.2%) | 30 (18.6%) |
Reduced susceptibility of serotypes to any of the antimicrobial agents tested, calculated both including and excluding cotrimoxazole. Each serotype/group was compared with all other serotypes. ns = not significant *Penicillin, erythromycin, chloramphenicol, cefotaxime, oxacillin, levofloxacin, linezolid, vancomycin.